Low-Molecular-Weight Heparin for the Treatment of Livedoid Vasculopathy

被引：5

作者：

Goerge, T. ^{[1
]}

机构：

[1] Univ klinikum Munster, Klin & Poliklin Dermatol & Venerol, Von-Esmarch-Str 58, D-48149 Munster, Germany

来源：

AKTUELLE DERMATOLOGIE | 2010年 / 36卷 / 12期

关键词：

D O I：

10.1055/s-0030-1255929

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

A 22 year old female patient presented with recurrent erythematous large confluent plaques with central ulcerations that were partly covered by crusts. In addition she had brownish maculae representing post inflammatory hyperpigmentation. The painful lesions are found in the maleolar region and the backs of both feet. The episodic disease first presented at age 11. Histologic analysis reveals luminal deposition of fibrin in the microcapillaries of the upper dermis. Livedoid vasculopathy was diagnosed. Treatment with low-molecular-weight heparin stopped the progression of ulceration.

引用

页码：484 / 487

页数：4

共 13 条

[1]

Callen J.P., Livedoid vasculopathy: What it is and how the patient should be evaluated and treated [comment], Arch Dermatol, 142, 11, pp. 1481-1482, (2006)

[2]

Deng A., Gocke C.D., Hess J., Et al., Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator [see comment], Arch Dermatol, 142, 11, pp. 1466-1469, (2006)

[3]

Papi M., Didona B., De Pita O., Et al., Livedo vasculopathy vs small vessel cutaneous vasculitis: Cytokine and platelet P-selectin studies [see comment], Arch Dermatol, 134, 4, pp. 447-452, (1998)

[4]

Jorizzo J.L., Livedoid vasculopathy: What is it? [comment], Arch Dermatol, 134, 4, pp. 491-493, (1998)

[5]

Sunderkotter C., De Groot K., Therapie von Vaskulitiden und Vaskulopathien, Hautarzt, 59, 5, pp. 382-393, (2008)

[6]

Erqou S., Kaptoge S., Et al., Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality, JAMA, 302, 4, pp. 412-423, (2009)

[7]

Goerge T., Weishaupt C., Metze D., Et al., Livedoid vasculopathy in a pediatric patient with elevated lipoprotein(a) levels: Prompt response to continuous low-molecular-weight heparin, Arch Dermatol, 146, 8, pp. 927-928, (2010)

[8]

Browning C.E., Callen J.P., Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia, Arch Dermatol, 142, 1, pp. 75-78, (2006)

[9]

Hairston B.R., Davis M.D., Gibson L.E., Drage L.A., Treatment of livedoid vasculopathy with low-molecular-weight heparin: Report of 2 cases [see comment], Arch Dermatol, 139, 8, pp. 987-990, (2003)

[10]

Hegemann B., Helmbold P., Marsch W.C., Livedoid vasculitis with ulcerations: The role of antithrombin III deficiency and its therapeutic consequences [erratum appears in Arch Dermatol 2002 Sep

← 1 2 →